Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorRudan, Igor
dc.contributor.authorAdeloye, Davies
dc.contributor.authorKatikireddi, Srinivasa Vittal
dc.contributor.authorMurray, Josie
dc.contributor.authorSimpson, Colin
dc.contributor.authorShah, Syed Ahmar
dc.contributor.authorRobertson, Chris
dc.contributor.authorSheikh, Aziz
dc.contributor.authorEAVE II collaboration
dc.date.accessioned2022-08-04T16:30:01Z
dc.date.available2022-08-04T16:30:01Z
dc.date.issued2021-12-25
dc.identifier280689924
dc.identifier18602514-b0ce-4894-a8e9-06f95e16256d
dc.identifier85123672649
dc.identifier35047182
dc.identifier.citationRudan , I , Adeloye , D , Katikireddi , S V , Murray , J , Simpson , C , Shah , S A , Robertson , C , Sheikh , A & EAVE II collaboration 2021 , ' The COVID-19 pandemic in children and young people during 2020-2021 : learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment ' , Journal of Global Health , vol. 11 , 01010 . https://doi.org/10.7189/JOGH.11.01010en
dc.identifier.issn2047-2978
dc.identifier.otherPubMedCentral: PMC8763336
dc.identifier.otherORCID: /0000-0002-1511-7944/work/116910275
dc.identifier.urihttps://hdl.handle.net/10023/25775
dc.descriptionFunding: EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care.). SVK acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2) and the Scottish Government Chief Scientist Office (SPHSU17).en
dc.description.abstractThe initial research questions posed by the scientists faced with SARS-CoV-2 outbreaks were focused on documenting the clinical presentation and the characteristics of the spread of the SARS-CoV-2 virus among CYP [1-3], and the optimal ways to diagnose CYP and treat those in need [1,4]. It quickly became apparent that younger age groups have a considerably milder clinical presentation, but also that they can very rarely develop a considerably more serious Multisystem Inflammatory Syndrome in Children (MISC) [1]. A special interest arose in how best to protect those particularly vulnerable. In this Editorial, we discuss the development of scientific evidence related to those research questions in children and young people during the first two years of the COVID-19 pandemic, based on the information available until December 1st, 2021
dc.format.extent16
dc.format.extent901659
dc.language.isoeng
dc.relation.ispartofJournal of Global Healthen
dc.subjectCOVID-19en
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectHealth Policyen
dc.subjectPublic Health, Environmental and Occupational Healthen
dc.subject3rd-DASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectNISen
dc.subject.lccRA0421en
dc.titleThe COVID-19 pandemic in children and young people during 2020-2021 : learning about clinical presentation, patterns of spread, viral load, diagnosis and treatmenten
dc.typeJournal itemen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Education Divisionen
dc.identifier.doi10.7189/JOGH.11.01010
dc.description.statusPeer revieweden
dc.identifier.urlhttps://jogh.org/2021/jogh-11-01010en


This item appears in the following Collection(s)

Show simple item record